| Bioactivity | Abefolastat tesaroxetan (SarbisPSMA) is a bivalent sarcophagine conjugate. Abefolastat tesaroxetan (SarbisPSMA) can be readily radiolabeled with positron-emitting copper-64 at room temperature and outperforms the monomeric agent with respect to tumor uptake and retention. Abefolastat tesaroxetan (SarbisPSMA) can be used for prostate cancer research[1]. |
| Name | Abefolastat tesaroxetan |
| CAS | 2254661-83-9 |
| Formula | C100H150N20O24 |
| Molar Mass | 2016.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zia NA, et al. A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 with High Tumor Uptake and Retention. Angew Chem Int Ed Engl. 2019 Oct 14;58(42):14991-14994. |
Abefolastat tesaroxetan
CAS: 2254661-83-9 F: C100H150N20O24 W: 2016.38
Abefolastat tesaroxetan (SarbisPSMA) is a bivalent sarcophagine conjugate. Abefolastat tesaroxetan (SarbisPSMA) can be r
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.